# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-029507
Filing Date
2025-02-28
Accepted
2025-02-28 07:00:18
Documents
105
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | apls-20241231.htm iXBRL | 10-K | 4354685
2 | EX-21.1 | apls-ex21_1.htm | EX-21.1 | 26285
3 | EX-23.1 | apls-ex23_1.htm | EX-23.1 | 3524
4 | EX-31.1 | apls-ex31_1.htm | EX-31.1 | 17419
5 | EX-31.2 | apls-ex31_2.htm | EX-31.2 | 17429
6 | EX-32.1 | apls-ex32_1.htm | EX-32.1 | 9984
7 | EX-32.2 | apls-ex32_2.htm | EX-32.2 | 9727
8 | GRAPHIC | img139103030_0.jpg | GRAPHIC | 89803
9 | GRAPHIC | img139103030_1.jpg | GRAPHIC | 49742
10 | GRAPHIC | img139103030_2.jpg | GRAPHIC | 60321
11 | GRAPHIC | img139103030_3.jpg | GRAPHIC | 77667
12 | GRAPHIC | img139103030_4.jpg | GRAPHIC | 163945
| Complete submission text file | 0000950170-25-029507.txt |  | 17255085

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
13 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | apls-20241231.xsd | EX-101.SCH | 2267675
108 | EXTRACTED XBRL INSTANCE DOCUMENT | apls-20241231_htm.xml | XML | 2830659

Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

EIN.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38276 | Film No.: 25682513
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)